Russell Investments Group, Ltd. Sangamo Therapeutics, Inc Transaction History

Russell Investments Group, Ltd.

  • $69.8 Billion
  • Q4 2024

A detailed history of Russell Investments Group, Ltd. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 26,314 shares of SGMO stock, worth $25,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,314
Previous 40,806 35.51%
Holding current value
$25,787
Previous $35,000 25.71%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$0.78 - $2.87 $11,303 - $41,592
-14,492 Reduced 35.51%
26,314 $26,000
Q3 2024

Nov 13, 2024
BUY
$0.32 - $1.1 $5,833 - $20,051
18,229 Added 80.74%
40,806 $35,000
Q2 2024

Aug 08, 2024
BUY
$0.36 - $0.65 $5,867 - $10,594
16,299 Added 259.62%
22,577 $8,000
Q1 2024

May 08, 2024
SELL
$0.42 - $1.38 $39,792 - $130,746
-94,744 Reduced 93.79%
6,278 $4,000
Q4 2023

Feb 05, 2024
SELL
$0.3 - $0.63 $383 - $805
-1,279 Reduced 1.25%
101,022 $54,000
Q3 2023

Nov 13, 2023
SELL
$0.58 - $1.47 $1,384 - $3,508
-2,387 Reduced 2.28%
102,301 $61,000
Q2 2023

Aug 10, 2023
SELL
$1.11 - $1.74 $101,251 - $158,719
-91,218 Reduced 46.56%
104,688 $136,000
Q1 2023

May 09, 2023
BUY
$1.66 - $3.67 $156,944 - $346,980
94,545 Added 93.28%
195,906 $344,000
Q3 2022

Nov 04, 2022
BUY
$4.27 - $6.39 $290,193 - $434,270
67,961 Added 203.48%
101,361 $496,000
Q2 2022

Jul 29, 2022
BUY
$3.28 - $6.21 $109,552 - $207,414
33,400 New
33,400 $138,000
Q2 2021

Aug 04, 2021
SELL
$10.17 - $12.64 $790,351 - $982,304
-77,714 Closed
0 $0
Q1 2021

May 10, 2021
SELL
$10.88 - $17.05 $352,174 - $551,891
-32,369 Reduced 29.4%
77,714 $964,000
Q4 2020

Feb 08, 2021
SELL
$9.23 - $18.18 $62,653 - $123,405
-6,788 Reduced 5.81%
110,083 $1.72 Million
Q3 2020

Nov 09, 2020
BUY
$9.38 - $12.48 $79,730 - $106,080
8,500 Added 7.84%
116,871 $1.1 Million
Q2 2020

Aug 05, 2020
BUY
$6.21 - $11.83 $317,275 - $604,406
51,091 Added 89.2%
108,371 $971,000
Q1 2020

May 06, 2020
SELL
$5.05 - $8.85 $222,260 - $389,506
-44,012 Reduced 43.45%
57,280 $364,000
Q3 2019

Nov 01, 2019
BUY
$9.05 - $12.22 $16,588 - $22,399
1,833 Added 1.84%
101,292 $917,000
Q4 2018

Feb 11, 2019
SELL
$9.51 - $16.6 $61,196 - $106,821
-6,435 Reduced 6.08%
99,459 $1.14 Million
Q3 2018

Oct 26, 2018
BUY
$13.05 - $19.05 $913,291 - $1.33 Million
69,984 Added 194.89%
105,894 $1.8 Million
Q1 2018

May 11, 2018
SELL
$16.7 - $26.35 $50,851 - $80,235
-3,045 Reduced 7.82%
35,910 $682,000
Q4 2017

Feb 06, 2018
SELL
$11.6 - $17.35 $367,940 - $550,324
-31,719 Reduced 44.88%
38,955 $665,000
Q3 2017

Nov 07, 2017
BUY
$8.4 - $15.0 $593,661 - $1.06 Million
70,674
70,674 $1.06 Million

Others Institutions Holding SGMO

# of Institutions
141
Shares Held
60.4M
Call Options Held
1.46M
Put Options Held
1.84M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $153M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email